According to a study led by researchers at the School of Medicine, diagnoses of breast cancer have increased steadily in women under age 50 over the past two decades. Studying such trends may offer clues to possible prevention strategies.
The Needleman Program for Innovation and Commercialization provides funding for researchers developing promising new therapeutics. A second call for proposals is now open. The deadline is March 15.
One of the world’s largest neuroscience research buildings was dedicated Jan. 18 on the Medical Campus. The 11-story building is named the Jeffrey T. Fort Neuroscience Research Building, in recognition of a gift from Fort, a longtime university supporter.
The School of Medicine has joined the Pediatric Heart Network, a multicenter collaboration of leading hospitals and research institutions that works to improve care for pediatric heart disease patients.
Gregory J. Zipfel, MD, head of the Department of Neurosurgery at the School of Medicine, has been awarded the Ralph G. Dacey Jr., MD, Medal for Outstanding Cerebrovascular Research.
Jennie H. Kwon, DO, an associate professor of medicine in infectious diseases, and Jason G. Newland, MD, a professor of pediatrics, both at the School of Medicine, have been selected to serve on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria.
Washington University in St. Louis and Deerfield Management, a health-care investment firm, announced the launch of VeritaScience, a new private R&D collaboration designed to advance the discovery, clinical development and commercialization of promising therapeutic and diagnostic candidates with potential to benefit human health.
Three WashU researchers developing promising therapeutics for cancer and heart disease are the inaugural awardees of the Needleman Program for Innovation and Commercialization. The next round of project proposals is now open.
At the university’s Board of Trustees meeting Dec. 1, numerous faculty members were appointed or promoted with tenure or granted tenure.
Todd A. Fehniger, MD, PhD, and colleagues Alice Y. Zhou, MD, PhD, Ryan C. Fields, MD, and George Ansstas, MD, all at the School of Medicine, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.
View More Stories